We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Insulet
PODD
$11.8B
| $26.6M | 0.12% |
96,741
-47,100
| -33% | -$12.8M |
|
227
Mercado Libre
MELI
$94.5B
| $26.5M | 0.12% |
+16,992
| New | +$24.9M |
|
228
Elevance Health
ELV
$81.5B
| $26.4M | 0.12% |
69,260
+34,760
| +101% | +$13.3M |
|
229
Payoneer
PAYO
$2.41B
| $26.1M | 0.12% |
+2,519,290
| New | +$26.5M |
|
230
PVH
PVH
$4.07B
| $25.9M | 0.12% |
240,952
-324,928
| -57% | -$35.7M |
|
231
Otis Worldwide
OTIS
$27.9B
| $25.9M | 0.12% |
316,839
-878,630
| -73% | -$67.6M |
|
232
LPL Financial
LPLA
$27B
| $25.6M | 0.11% |
189,400
+172,100
| +995% | +$25M |
|
233
CALL
The Mosaic Company
MOS
$7.19B
| $25.5M | 0.11% |
+800,000
| New | +$27.1M |
|
|
CMRX
234
DELISTED
Chimerix, Inc.
CMRX
| $25.5M | 0.11% |
3,182,892
-1,399,980
| -31% | -$11.6M |
|
235
Ichor Holdings
ICHR
$2.17B
| $25.1M | 0.11% |
466,200
+171,497
| +58% | +$9.44M |
|
236
Lockheed Martin
LMT
$131B
| $24.8M | 0.11% |
+65,545
| New | +$25.2M |
|
237
Vail Resorts
MTN
$5.7B
| $24.6M | 0.11% |
+77,857
| New | +$24.8M |
|
238
Liberty Global Class C
LBTYK
$3.5B
| $24.6M | 0.11% |
911,100
+894,300
| +5,323% | +$24.1M |
|
239
ICICI Bank
IBN
$107B
| $24.5M | 0.11% |
1,434,100
+455,396
| +47% | +$7.58M |
|
240
Arcutis Biotherapeutics
ARQT
$3.48B
| $24.5M | 0.11% |
896,400
+457,100
| +104% | +$12.9M |
|
|
AAMI
241
Acadian Asset Management
AAMI
$2.88B
| $24.3M | 0.11% |
1,035,600
-84,946
| -8% | -$1.93M |
|
242
Danaher
DHR
$138B
| $24.1M | 0.11% |
101,218
-272,350
| -73% | -$60.4M |
|
243
Marriott International
MAR
$100B
| $24.1M | 0.11% |
+176,250
| New | +$25.4M |
|
244
Upstart Holdings
UPST
$2.55B
| $24M | 0.11% |
+192,100
| New | +$23.6M |
|
245
NiSource
NI
$21.5B
| $23.9M | 0.11% |
+975,800
| New | +$24.8M |
|
|
LEV
246
DELISTED
The Lion Electric Company
LEV
| $23.9M | 0.11% |
+1,228,457
| New | +$23M |
|
247
PG&E
PCG
$39B
| $23.9M | 0.11% |
2,345,300
-1,286,045
| -35% | -$13.8M |
|
248
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$3.75B
| $23.7M | 0.11% |
+550,000
| New | +$23.9M |
|
249
ServiceNow
NOW
$120B
| $23.4M | 0.11% |
213,000
+160,805
| +308% | +$16.3M |
|
250
Krystal Biotech
KRYS
$10.7B
| $23.2M | 0.1% |
340,900
+171,900
| +102% | +$12M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.